Table 1.
Sample ID | Gender | Age | Ethnicity | Histology | Therapy Agent | Pre or Post NAC | Disease Status | Experiment |
---|---|---|---|---|---|---|---|---|
BGB987445 | Male | 80 | Not Hispanic or Latino | Urothelial | GemCIS | Pre NAC | Dead from disease | PDX Growth Optimization (Fresh-Minced) |
BGB420711 | Male | 72 | Not Hispanic or Latino | Urothelial | MVAC | Pre NAC | Alive NED | PDX Growth Optimization (Fresh-Minced) |
BGB649851 | Male | 71 | Not Hispanic or Latino | Urothelial | No NAC | NA | Alive NED | PDX Growth Optimization (Fresh-Minced) |
BGB247270 | Male | 83 | Not Hispanic or Latino | Urothelial w/85% Squamous | 5-FU/MMC | Pre Chemo/XRT | Alive with disease | PDX Growth Optimization (Fresh-Fragment) |
BGB676371 | Male | 62 | Hispanic or Latino | Urothelial | MVAC | Pre NAC | Alive NED | PDX Growth Optimization (Fresh-Fragment) |
BGB691147 | Female | 59 | Not Hispanic or Latino | Squamous | Unknown | Pre Chemo | Alive with disease | PDX Growth Optimization (Fresh-Fragment) |
BGB687812 | Male | 78 | Not Hispanic or Latino | Urothelial | No NAC | NA | Alive, disease status unknown | PDX Growth Optimization (Cryo-Fragment) |
BGB864465 | Male | 48 | Not Hispanic or Latino | Urothelial | GemCIS | Pre NAC | Alive NED | PDX Growth Optimization (Cryo-Fragment) |
BGB248720 | Male | 79 | Not Hispanic or Latino | Urothelial | No NAC | NA | Alive NED | PDX Growth Optimization (Cryo-Fragment) |
BGB331255 | Male | 77 | Hispanic or Latino | Urothelial | GemCIS | Pre NAC | Alive NED | PDX Growth Optimization (Cryo, Fresh-Fragment) |
BGB490421 | Male | 92 | Not Hispanic or Latino | Urothelial | Capecitabine | Post NAC | Alive with disease | Chemotherapy Test |
BGB450466 | Female | 70 | Not Hispanic or Latino | Urothelial | GemCIS | Pre NAC | Dead from disease | Chemotherapy Test |
BGB680543 | Male | 61 | Black or African American | Urothelial | GemCIS + Celecoxib + Pembro | Pre NAC | Alive NED | Chemotherapy Test |
BGB448649 | Male | 72 | Not Hispanic or Latino | Urothelial | Gemcitabine | Pre NAC | Alive with disease | Chemotherapy Test |
BGB450544 | Male | 63 | Not Hispanic or Latino | Urothelial | GemCIS | Pre NAC | Alive with disease | Chemotherapy Test |
BGB510249 | Female | 67 | Not Hispanic or Latino | Urothelial | GemCIS | Pre NAC | Dead from disease | Chemotherapy Test |
BGB450466 | Female | 70 | Not Hispanic or Latino | Urothelial | GemCIS | Post NAC | Dead from disease | Kinase Inhibitor |
BGB352747 | Male | 82 | Not Hispanic or Latino | Urothelial | GemCIS | Post NAC | Dead from disease | Kinase Inhibitor |
BGB644697 | Male | 61 | Not Hispanic or Latino | Urothelial | GemCIS | Pre NAC | Alive NED | Kinase Inhibitor |
BGB581979 | Male | 72 | Not Hispanic or Latino | Urothelial | Gemcitabine + Cisplatin + Pembro | Post NAC | Deceased with unknown cause | Kinase Inhibitor |
BGB540726 | Male | 56 | Not Hispanic or Latino | Urothelial | GemCIS | Post NAC | Dead from disease | Kinase Inhibitor |
BGB352747 | Male | 82 | Not Hispanic or Latino | Urothelial | GemCIS | Post NAC | Dead from disease | Kinase Inhibitor |